|
Index of reports
> Cases with Osteoporosis (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Estrace (Estradiol Vaginal) where reactions include osteoporosis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Estrace side effects in 59 year old female
Reported by a physician from United States on 2012-03-02
Patient: 59 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Contusion, Femur Fracture, Joint Hyperextension, Hand Fracture, Cyst, Loss of Consciousness, Breast Cyst, Tongue Disorder, DRY Mouth, Muscle Injury, Cervical Spinal Stenosis, LOW Turnover Osteopathy, Muscle Spasms, Pain in Extremity, Laceration, Bursitis, Stress, Seasonal Allergy, Stress Fracture, Osteoporosis, Haemorrhage, Drug Interaction, Fracture Nonunion, Fall, Periodontitis, Foot Fracture, Limb Crushing Injury, Bone Loss, Fibrocystic Breast Disease, Malignant Melanoma, Blood Cholesterol Increased, Humerus Fracture, Tooth Fracture, Breast Disorder, Dental Caries, Bruxism, Meniscus Lesion, Osteoarthritis, Gingival Recession, Impaired Healing, Spinal Osteoarthritis, Tooth Disorder, Hypertension
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Start date: 2001-01-01
End date: 2002-04-01
Fosamax
Administration route: Oral
Start date: 2003-05-01
End date: 2005-04-01
Femhrt
Estrace
Fosamax
Administration route: Oral
Indication: Osteopenia
Start date: 1996-01-01
End date: 2001-01-01
Other drugs received by patient: Progesterone; Vioxx; Premarin; Calcium (Unspecified)
Possible Estrace side effects in 59 year old female
Reported by a consumer/non-health professional from United States on 2012-01-12
Patient: 59 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Femur Fracture, Contusion, Joint Hyperextension, Hand Fracture, Cyst, Loss of Consciousness, Breast Cyst, Tongue Disorder, Muscle Injury, DRY Mouth, Cervical Spinal Stenosis, LOW Turnover Osteopathy, Muscle Spasms, Pain in Extremity, Laceration, Bursitis, Stress, Seasonal Allergy, Stress Fracture, Haemorrhage, Osteoporosis, Drug Interaction, Periodontitis, Fracture Nonunion, Fall, Foot Fracture, Limb Crushing Injury, Bone Loss, Fibrocystic Breast Disease, Malignant Melanoma, Blood Cholesterol Increased, Humerus Fracture, Tooth Fracture, Breast Disorder, Dental Caries, Bruxism, Meniscus Lesion, Osteoarthritis, Gingival Recession, Impaired Healing, Spinal Osteoarthritis, Hypertension, Tooth Disorder
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
Indication: Osteopenia
Start date: 1996-01-01
End date: 2001-01-01
Fosamax
Administration route: Oral
Start date: 2003-05-01
End date: 2005-04-01
Estrace
Fosamax
Administration route: Oral
Start date: 2001-01-01
End date: 2002-04-01
Femhrt
Other drugs received by patient: Premarin; Vioxx; Calcium (Unspecified); Progesterone
Possible Estrace side effects in female
Reported by a lawyer from United States on 2012-01-03
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Osteoporosis, Breast Cancer Female
Drug(s) suspected as cause:
Estradiol
Dosage: unk
Start date: 1997-10-01
End date: 2002-08-01
Provera
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1991-05-20
End date: 1997-06-24
Provera
Dosage: unk
Start date: 1997-10-01
End date: 2002-08-01
Cycrin
Dosage: unk
Start date: 1997-10-01
End date: 2002-08-01
Estrace
Dosage: unk
Start date: 1991-05-20
End date: 1997-06-24
Estrace
Dosage: unk
Start date: 1997-10-01
End date: 2002-08-01
Medroxyprogesterone Acetate
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-02-01
End date: 2003-06-01
Vagifem
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2003-05-23
Estrace
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-02-01
End date: 2003-06-01
Estradiol
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-02-01
End date: 2003-06-01
Cycrin
Dosage: unk
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-02-01
End date: 2003-06-01
|
